Search

A team at MSK uncovered how TRX518, a new immunotherapy drug in early development, works in the body.

Memorial Sloan Kettering Cancer Center (MSK) today announced the launch of its new Teen and Young Adult (TYA) Program, TYA  @  MSK, which will offer special services to MSK’s TYA population. In tandem, MSK officially opened The Lounge, a space designed especially for this unique age group that was made possible by a $1 million donation from Teen Cancer America. The nonprofit organization, co-founded by Roger Daltrey and Pete Townshend of The Who, partners with hospitals throughout the United States to develop specialized facilities for teens and young adults with cancer.

According to Memorial Sloan Kettering scientists, it has to do with what the virus does to a cell’s DNA repair machinery.

Charles L. Sawyers, MD, Investigator, Howard Hughes Medical Institute (HHMI); Marie-Josée and Henry R. Kravis Chair in Human Oncology and Pathogenesis; Chair, Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center (MSK), has been elected to the National Academy of Medicine (NAM) Council, the Academy’s governing and oversight body, for a three-year term.

Memorial Sloan Kettering Cancer Center has announced the appointment of surgical oncologist Richard Barakat to the new position of Deputy Physician-in-Chief for the Memorial Sloan Kettering Regional Care Network and Alliance.

Elizabeth Cruz has been a nurse at Memorial Sloan Kettering for more than ten years. Learn more about what drives her.

COVID-19 vaccines represent a step towards ending the pandemic and getting back to a sense of normalcy after enduring more than a year of isolation, social distancing, and other measures to control the spread of the coronavirus.